This ticker has not been starred yet VRNA Verona Pharma Plc
Pharmaceutical Preparations
Book value per $ invested $ 0.00
Leverage 65.82%
Market Cap $ 29.1B
PE 0.00
Dividend Yield 0.00%
Profit $ -153.0m
Margin 3777.31%

Verona Pharma plc, a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapies for the treatment of respiratory diseases with unmet medical needs. The company is headquartered in London, the United Kingdom.

Subscribe Now For Access - Only $1.99 Per Month